| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a topical pharmaceutical preparation for treating inflammatory skin pathologies, preferentially an ischemia-related skin pathology. The above preparation contains a supernatant of normal saline prepared by culturing for at least 1 hour peripheral blood mononuclear cells (PBMC) or their subpopulation in normal saline free from substances promoting the PBMC proliferation and activating the PBMC in the stress-inducing environment. Also, the invention refers to a method for producing and using the above preparation.EFFECT: invention promotes relieving the symptoms of the inflammatory skin pathologies and the healing process.20 cl, 18 dwg, 5 ex |
